WO2022145166A1 - Composition for oral use - Google Patents

Composition for oral use Download PDF

Info

Publication number
WO2022145166A1
WO2022145166A1 PCT/JP2021/043963 JP2021043963W WO2022145166A1 WO 2022145166 A1 WO2022145166 A1 WO 2022145166A1 JP 2021043963 W JP2021043963 W JP 2021043963W WO 2022145166 A1 WO2022145166 A1 WO 2022145166A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
component
oral composition
mass
salts
Prior art date
Application number
PCT/JP2021/043963
Other languages
French (fr)
Japanese (ja)
Inventor
駿太 石井
将登 平泉
竜 小久保
Original Assignee
ライオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライオン株式会社 filed Critical ライオン株式会社
Priority to CN202180087622.0A priority Critical patent/CN116634986A/en
Priority to JP2022572945A priority patent/JPWO2022145166A1/ja
Publication of WO2022145166A1 publication Critical patent/WO2022145166A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to an oral composition.
  • the feeling of cleaning the dentifrice that is, the smooth and smooth texture of the tooth surface (smoothness) is pronounced of bright white teeth, and it is a feeling that greatly contributes to the satisfaction of tooth brushing behavior as well as the feeling of preventing bad breath.
  • the smooth feeling of the tooth is obtained in a state where the surface of the tooth is cleaned, and this includes, for example, a means such as chemical removal with a chelating agent.
  • the actual feeling of the effect is usually recognized as the smoothness of the tooth surface when the toothpaste user traces the surface of the tooth with the tongue after brushing, that is, a smooth feel (smooth feel).
  • a cooling sensation agent may be added.
  • Patent Document 1 a dentin composition containing N- (4-cyanomethylphenyl) -2-isopropyl-5-methylcyclohexanecarboxamide and sodium polyacrylate and / or sodium alginate is described as persistent. It is described that it can provide a high oral cleanliness and a good feeling of use.
  • Patent Document 2 a dentifrice composition containing a chelating agent and N- (4-cyanomethylphenyl) -2-isopropyl-5-methylcyclohexanecarboxamide gives a high oral cleaning sensation and an excellent halitosis prevention sensation.
  • Patent Document 3 describes that an oral care composition containing a polyphosphorylated compound and a cooling sensation agent such as menthol has a whitening and stain-preventing effect.
  • the stains on the teeth can be cleanly removed from the irritation of the tongue by the cooling sensation agent. It may not be possible to fully realize the "smoothness of the tooth surface".
  • the amount of the cooling sensation agent is increased in order to improve the sustainability required for the feeling of prevention of bad breath, the influence on the sensation of the tongue becomes large, and the smooth feeling of the teeth becomes more difficult to feel.
  • an object of the present invention is to provide an oral composition capable of exhibiting both a feeling of preventing bad breath and a feeling of slipperiness while suppressing irritation in the oral cavity.
  • the present invention provides the following [1] to [11].
  • [1] (A) Chelating agent and (B) An oral composition containing N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
  • [2] The oral composition according to [1], wherein the component (A) contains at least one selected from the group consisting of condensed phosphoric acid, organic acids, salts thereof, and polyacrylic acid salts.
  • the component (A) contains at least one of the following: Condensed phosphoric acid and its salt, which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid and salts thereof; One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof; and salts thereof; Polyacrylic acid salt which is sodium polyacrylate.
  • Condensed phosphoric acid and its salt which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid and salts thereof
  • One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof
  • Polyacrylic acid salt which is sodium polyacrylate.
  • an oral composition capable of exhibiting both a feeling of preventing bad breath and a feeling of smoothness while suppressing irritation in the oral cavity.
  • the oral composition of the present invention contains the following components (A) and (B), and preferably further contains the component (C).
  • the component (A) is a chelating agent.
  • the chelating agent include condensed phosphoric acid and its salt, organic acid and its salt, and polyacrylic acid salt. That is, the component (A) preferably contains one or more selected from the group consisting of condensed phosphoric acid, organic acids, salts thereof, and polyacrylic acid salts.
  • Condensed phosphoric acid and salts thereof include linear polyphosphoric acids such as pyrophosphoric acid, tripolyphosphoric acid, tetrapolyphosphoric acid, and polyphosphoric acid having a higher degree of polymerization and salts thereof; trimetaphosphate, tetramethaphosphate, hexametaphosphate. Such as cyclic polyphosphoric acid and salts thereof.
  • the salt include alkali metal salts such as sodium salt and potassium salt.
  • pyrophosphate, polyphosphate and hexametaphosphate are preferable, and sodium pyrophosphate, sodium polyphosphate and sodium hexametaphosphate are more preferable.
  • Examples of the organic acid and its salt include oxalic acid, malonic acid, maleic acid, fumaric acid, lactic acid, malic acid, tartrate acid, citric acid, pyruvate acid, oxaloacetic acid, aspartic acid, succinic acid, glucuronic acid, adipic acid, and the like.
  • Examples thereof include phytic acid, phthalic acid, acetic acid, and salts thereof (for example, alkali metal salts such as sodium salt and potassium salt).
  • malic acid, tartaric acid, citric acid, succinic acid, lactic acid, and phytic acid, and salts thereof are preferable, and malic acid, phytic acid, or salts thereof are more preferable.
  • a linear polyacrylic acid salt can be used, and it is preferable to use a polyacrylic acid salt having a weight average molecular weight (Mw) of 1,000 or more and 20,000 or less.
  • Mw weight average molecular weight
  • the weight average molecular weight can be measured using a gel permeation chromatograph / multi-angle laser light scattering detector (GPC-MALLS) under the following conditions.
  • Mobile phase 0.3M NaClO 4 NaN 3
  • aqueous solution column TSKgel ⁇ -M 2 pre-columns: TSK guardgroup ⁇ Standard substance: Polyethylene glycol
  • the polyacrylic acid salt examples include alkali metal salts such as sodium salt and potassium salt.
  • the polyacrylic acid salt is preferably sodium polyacrylate.
  • the component (A) may be one kind or a combination of two or more kinds.
  • the component (A) preferably contains at least one of the following: Condensed phosphoric acid and its salt, which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid, and salts thereof; One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof; and salts thereof; Polyacrylic acid salt which is sodium polyacrylate.
  • the content of the component (A) is usually 0.05% by mass or more, preferably 0.1% by mass or more, based on the entire oral composition (100% by mass). Thereby, a better stain removing effect can be obtained.
  • the upper limit is usually 3.5% by mass or less, preferably 3% by mass or less, and more preferably 2.5% by mass or less. As a result, it is possible to suppress a decrease in usability due to excessive stimulation to the oral cavity. Therefore, the content of the component (A) is usually 0.05 to 3.5% by mass, preferably 0.1 to 3% by mass, and more preferably 0.1 to 2.5% by mass.
  • the component (B) is N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
  • the content of the component (B) is usually 0.000005% by mass or more, preferably 0.00001% by mass or more, more preferably 0.00005% by mass or more, based on the entire oral composition (100% by mass). Is. As a result, a good feeling of prevention of bad breath can be obtained.
  • the upper limit is usually 0.5% by mass or less, preferably 0.1% by mass or less, and more preferably 0.005% by mass or less. As a result, it is possible to prevent the stimulus from becoming too strong and the slippery feeling from being lowered. Therefore, the content of the component (A) is usually 0.000005 to 0.5% by mass, preferably 0.00001 to 0.1% by mass, and more preferably 0.00005 to 0.005% by mass. be.
  • the component (C) is an abrasive.
  • the abrasive may be either an inorganic abrasive or an organic abrasive.
  • the preferred RDA value (Radioactive Dentin Abrasion Values) of the abrasive is not particularly limited.
  • the RDA value is usually 50 or more, particularly preferably 50 to 200.
  • examples of the inorganic polishing agent include silica-based polishing agents such as anhydrous silicic acid, crystalline silica, amorphous silica, silica gel, aluminosilicate, zirconosilicate, zeolite, precipitated silica, and titanium-binding silica; hydrogen phosphate.
  • silica-based polishing agents such as anhydrous silicic acid, crystalline silica, amorphous silica, silica gel, aluminosilicate, zirconosilicate, zeolite, precipitated silica, and titanium-binding silica; hydrogen phosphate.
  • organic abrasive examples include synthetic resin-based abrasives and polymethylmethacrylate.
  • an inorganic abrasive is preferable, a silica-based abrasive and an aluminum-based abrasive are more preferable, and one or more selected from the group consisting of silicic acid anhydride and aluminum oxide is more preferable.
  • the abrasive silica is preferably abrasive particles having an average particle size of 1 to 40 ⁇ m, and the BET specific surface area of the abrasive silica is preferably 80 to 250 square meters per gram.
  • the average particle size of the abrasive silica is a volume-based median diameter (D50) measured by a laser diffraction / scattering method.
  • Commercially available products can be used as the silica-based polishing agent, for example, ZEODENT (registered trademark) 124, ZEODENT (registered trademark) 113 manufactured by Evonic, Tixosil (registered trademark) 73, Tixosil (registered trademark) 63 manufactured by Solvay. , Polishable silica, zirconosilicate, aluminosilicate, etc. manufactured by Taki Chemical Co., Ltd. can be mentioned.
  • the abrasive may be a granulated product.
  • granulated products include particles obtained by granulating water-insoluble powder (for example, silica gel) into granules.
  • a conventionally known arbitrary suitable binder may be used.
  • the component (C) may be used alone or in combination of two or more. In the case of a combination of two or more kinds, the combination of the above-mentioned abrasive particles and the granulated product may be included.
  • the content thereof is usually 1% by mass or more, preferably 2% by mass or more, based on the entire oral composition (100% by mass). This makes it possible to enhance the cleaning power against stains such as stains.
  • the upper limit is usually 35% by mass or less, preferably 30% by mass or less, and more preferably 20% by mass or less. Thereby, the occurrence of oral mucosal irritation can be suppressed. Therefore, the content of the component (C) is usually 1 to 35% by mass, preferably 2 to 30% by mass, and more preferably 2 to 20% by mass.
  • the component (D) is a lactone having 6 to 12 carbon atoms (hereinafter, the number of carbon atoms is shown as a number attached to "C" representing a carbon atom). That is, it is preferable that the oral composition further contains the lactone which is the component (D).
  • the number of carbon atoms constituting the ring structure is not particularly limited.
  • the oral composition By containing the component (D), the oral composition can be given a sweetness during and after use, and the bitterness derived from the component (A) can be suppressed, thereby improving the feeling of use.
  • component (D) examples include C6: ⁇ -hexalactone, C7: ⁇ -heptalactone, C8: ⁇ -octalactone, C9: ⁇ -nonalactone, C10: ⁇ -decalactone, and C11: ⁇ . -Undecalactone, C12: ⁇ -dodecalactone, C6: ⁇ -hexalactone, C7: ⁇ -heptalactone, C8: ⁇ -octalactone, C9: ⁇ -nonalactone, C10: ⁇ -decalactone, C11: ⁇ -un Decalactone, C12: ⁇ -dodecalactone.
  • the component (D) it is preferable to use a lactone having 6 to 11 carbon atoms, and specifically, a lactone containing a 5-membered ring ( ⁇ -lactone) and a lactone containing a 6-membered ring ( ⁇ -lactone) are used. It is preferable to use a lactone containing a 5-membered ring ( ⁇ -lactone). As the component (D), one or more of these can be used. That is, it is preferable that the oral composition further contains at least one selected from the group consisting of lactones having 6 to 12 carbon atoms as the component (D).
  • the content thereof is usually 0.0000001% by mass or more, preferably 0.000005% by mass or more, based on the total amount of the oral composition (100% by mass). It is preferably 0.00001% by mass or more. As a result, good sweetness can be imparted and bitterness can be suppressed.
  • the upper limit is usually 0.2% by mass or less, preferably 0.1% by mass or less, and more preferably 0.05% by mass or less. As a result, it is possible to prevent the sweetness from becoming too strong and the oral composition from being used poorly. Therefore, the content of the component (D) is usually 0.000001 to 0.2% by mass, preferably 0.000005 to 0.1% by mass, and more preferably 0.00001 to 0.05% by mass. be.
  • the oral composition may contain any component other than the components (A) to (D) already described, as long as the effect of the present invention is not impaired.
  • the optional component examples include a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent.
  • a surfactant e.g., a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent.
  • surfactant other than the component (C) examples include an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant.
  • anionic surfactant examples include alkyl sulfates, acyl amino acid salts, acyl taurine salts, ⁇ -olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates.
  • the alkyl group and the acyl group may be either a straight chain or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14.
  • the salt can be selected from pharmacologically acceptable salts.
  • Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts.
  • inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt
  • organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt
  • arginine salt and the like Basic amino acid salts of.
  • inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
  • alkyl sulfate examples include lauryl sulfate (sodium lauryl sulfate) and myristyl sulfate.
  • acyl amino acid salt examples include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine.
  • Acylglycine salts such as salts; N-lauroyl- ⁇ -alanine salt, N-myristyl- ⁇ -alanine salt, N-cocoyl- ⁇ -alanine salt, N-lauroyl-N-methyl- ⁇ -alanine salt, N-myristoyl Acylalanine salts such as -N-methyl- ⁇ -alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned.
  • the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt.
  • ⁇ -olefin sulfonate examples include ⁇ -olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate.
  • anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
  • the anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an ⁇ -olefin sulfonate.
  • nonionic surfactant examples include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkyrrole amide, and polyoxy.
  • the number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 5 to 30 mol.
  • the average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol.
  • the number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18.
  • the number of carbon atoms of the fatty acid of the polyoxyethylene sorbitan fatty acid ester is usually 16 to 18, and the average number of moles of ethylene oxide added is usually 10 to 40 mol.
  • the number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14.
  • the nonionic surfactant polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether are preferable.
  • amphoteric surfactant examples include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-.
  • alkyldimethylaminoacetic acid betaine eg, lauryldimethylaminoacetic acid betaine
  • fatty acid amide propyldimethylaminoacetic acid betaine eg, cocamidopropyl betaine
  • Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl
  • imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine
  • alkyl betaines such as lauryldimethylaminoacetic acid betaine.
  • the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
  • the content of the surfactant is preferably 5% by mass or less, preferably 0.1 to 5% by mass, and more preferably 0.5 to 3% by mass with respect to the entire oral composition (100% by mass). , More preferably 1 to 3% by mass.
  • sugar alcohols and polyhydric alcohols other than sugar alcohols are preferable.
  • sugar alcohol include sugar alcohols such as sorbitol, erythritol, martitol, lactitol, xylitol, and reduced starch saccharified; glycerin; polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol.
  • polyethylene glycol include polyethylene glycol having an average molecular weight of 150 to 6000, and polyethylene glycol having an average molecular weight of 190 to 630 is preferable. Specific examples thereof include PEG200, PEG300, PEG400 and PEG600.
  • the average molecular weight of polyethylene glycol is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
  • the content of the wetting agent is usually 40% by mass or less, preferably 1 to 30% by mass, based on the entire oral composition (100% by mass).
  • medicinal ingredients include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timol, hinokithiol, and lysoteam chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ⁇ -aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Glycyrrhetinic acid, glycyrrhetinic acid derivative (eg, stearyl glycyrrhetinate), anti-inflammatory agents such as allantinchlorhydroxy
  • fragrances other than any D component include peppermint oil, sparemint oil, Japanese peppermint oil, anis oil, cassia oil, eucalyptus oil, winter green oil, mastic oil, neroli oil (orange flower oil), and lemongrass oil.
  • the feeling of use can be further improved.
  • the sweetener include saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartylphenylalanine methyl ester and the like.
  • the above-exemplified sweetener may be used alone or in combination of two or more.
  • oily component examples include hydrocarbons such as squalane, liquid paraffin, vaseline, and microcrystalin wax; and having 8 carbon atoms such as higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, and isostearyl alcohol). ⁇ 22 alcohols); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), vegetable oils such as olive oil, castor oil, palm oil; Examples include fatty acid esters.
  • the antiseptic power of the preparation can be ensured.
  • the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like.
  • the preservative may be used alone or in combination of two or more.
  • any suitable organic binder conventionally known for example, a polysaccharide, a cellulosic binder (for example, carboxymethyl cellulose (CMC), hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, cation) Celluloseized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (eg, sodium polyacrylate, etc.) Cardovinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) can be mentioned.
  • CMC carboxymethyl cellulose
  • hydroxyethyl cellulose hydroxypropyl cellulose
  • hydroxypropylmethyl cellulose hydroxypropylmethyl cellulose
  • methyl cellulose c
  • inorganic binders such as thickening silica and aluminum silicate can also be mentioned.
  • the content of any organic binder is preferably 0 to 3% by mass, more preferably 0.1 to 2% by mass, based on the entire oral composition (100% by mass).
  • the content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
  • the pH stability of the pharmaceutical product can be ensured.
  • the optional pH adjuster include hydroxides such as sodium hydroxide and potassium hydroxide, phosphoric acid or a salt thereof, sodium hydrogen phosphate, sodium dihydrogen phosphate and the like.
  • the content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
  • the pH value usually means a value at 25 ° C. and 3 minutes after the start of measurement.
  • the pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
  • the colorant examples include natural pigments such as Benibana red pigment, Kuchinashi yellow element, Kuchinashi blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and tamarind pigment.
  • Legal dyes such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Riboflavin, Copper Chlorophine Sodium , Titanium dioxide and the like.
  • the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
  • the solvent examples include water (purified water) and ethanol.
  • water purified water
  • ethanol ethanol
  • the solvent one type may be used alone or two or more types may be used in combination.
  • optional ingredients examples include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber.
  • the content of these other optional components can be appropriately set as long as the effect of the present invention is not impaired.
  • the oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
  • the dosage form of the oral composition can be appropriately selected depending on the usage form, and is not particularly limited.
  • the dosage form is, for example, in the form of a paste or liquid, and if it is a dentifrice, it can be prepared as a dentifrice, a liquid dentifrice, a liquid dentifrice, or a dentifrice.
  • the method for producing the oral composition is not particularly limited.
  • Oral compositions can be prepared by their respective conventional methods, depending on the dosage form. For example, when it is used as a dentifrice, a method of preparing a component that dissolves in a solvent, mixing other insoluble components, and defoaming (for example, reducing the pressure) as necessary can be mentioned.
  • the toothpaste obtained by such a method can be contained in a container and made into a product.
  • the shape and material of the container are not particularly limited, and a container used for a normal dentifrice composition can be used. Examples of the container include a container such as a laminated tube made of plastic such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
  • A1 Sodium pyrophosphate (trade name: sodium pyrophosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
  • A2 Sodium polyphosphate (trade name: sodium polyphosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
  • A3 Sodium hexametaphosphate (trade name: sodium hexametaphosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
  • A4 Malic acid (trade name: malic acid, manufacturer: Fuso Chemical Industry Co., Ltd.)
  • A5 Phytic acid (trade name: phytic acid, manufacturer: Fuso Chemical Industry Co., Ltd.)
  • A6 Sodium polyacrylate (trade name: AC-10NPD, manufacturer: Toagosei Co., Ltd.)
  • N- (2-Hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide (trade name: Coolact® 370, manufacturer: Takasago International Corporation)
  • N-Ethyl-p-Menthane-3-carboxamide (trade name: WS-3, manufactured by Simrise Japan)
  • polishable silica (Tixosil® 73, manufactured by Solvay)
  • C2 Aluminum oxide (trade name: aluminum oxide, manufacturer: Nippon Light Metal Co., Ltd.)
  • -(D) component- D1 ⁇ -Hexalactone: (Manufacturer: Inoue Fragrance Co., Ltd.)
  • D2 ⁇ -Undecalactone: (Manufacturer: Inoue Fragrance Co., Ltd.)
  • ⁇ Evaluation method> It was evaluated by 4 subjects. A 1 g of sample dentifrice was placed on a toothbrush (Clinica Advantage toothbrush, 4-row compact, usually manufactured by Lion Corporation), and after brushing the teeth for 3 minutes, the oral cavity was rinsed once with 10 mL of water. The irritation in the oral cavity after use, the smooth feeling of teeth after use (easiness to feel smooth), the feeling of preventing bad breath, the lack of bitterness, and the good feeling of use are judged by the following score criteria, respectively, for 4 people. The average score was calculated and evaluated according to the following evaluation criteria.
  • the actual feeling of preventing bad breath means that a refreshing feeling is felt even after 60 minutes have passed after use
  • the good feeling of use means that there is no sarcasm due to bitterness or too strong sweetness.
  • composition of the fragrance is as follows. Peppermint oil 50% by mass Peppermint refined oil (20% cut in front flow) 5% by mass Peppermint refined oil (15% cut in front and back flow) 5% by mass Spearmint oil 1% by mass Spearmint refined oil (20% cut in front flow) 1% by mass Japanese mint oil 1% by mass Japanese mint refined oil (30% cut in front flow) 1% by mass Menthol 10% by mass Carvone 1% by mass Anethole 5% by mass Solvent balance 100% by mass in total
  • Comparative Example 11 Although there is no bitterness, the evaluation of the smoothness of the teeth is low, and in Comparative Example 12, which contains the components (A) and (C) but does not contain the component (B), the evaluation of the actual feeling of preventing bad breath is low. The bitterness was also strongly evaluated. On the other hand, in Examples 14 to 21 containing the component (A), the component (B) and the component (D), the evaluation of no bitterness is excellent by further containing the component (D), and the usability is good. The evaluation was also good.

Abstract

In view of problems in the prior art, the purpose of the present invention is to provide a composition for oral use that limits stimulation in the mouth while achieving both a sensation of preventing bad breath and the feeling that teeth are smooth and clean. The present invention provides a composition for for oral use such as a dentifrice, a mouthwash, a spray, a liniment, an adhesive patch, or an orally-dissolving drug, the composition containing: (A) a chelating agent such as a condensed phosphate, an organic acid, a salt of a condensed phosphate or organic acid, or a polyacrylate; and (B) N-(2-hydroxy-2-phenylethyl)-2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.

Description

口腔用組成物Oral composition
 本発明は、口腔用組成物に関する。 The present invention relates to an oral composition.
 歯磨剤の清掃実感、すなわち、歯の表面の滑らかなツルツルとした触感(ツルツル感)は、輝く白い歯を想起させ、口臭予防実感とともに歯磨行動の満足度に大きく寄与する実感である。歯のツルツル感は、歯の表面が清掃された状態で得られ、これは、例えば、キレート剤による化学的除去等の手段が挙げられる。そしてその効果実感は、通常、歯磨きユーザーが、歯磨後に歯の表面を舌でなぞったときの歯牙表面の滑らかさ、すなわち、ツルツルした感触(スムーズな感触)として認知される。 The feeling of cleaning the dentifrice, that is, the smooth and smooth texture of the tooth surface (smoothness) is reminiscent of bright white teeth, and it is a feeling that greatly contributes to the satisfaction of tooth brushing behavior as well as the feeling of preventing bad breath. The smooth feeling of the tooth is obtained in a state where the surface of the tooth is cleaned, and this includes, for example, a means such as chemical removal with a chelating agent. The actual feeling of the effect is usually recognized as the smoothness of the tooth surface when the toothpaste user traces the surface of the tooth with the tongue after brushing, that is, a smooth feel (smooth feel).
 他方、口腔用組成物に口臭予防実感を付与する手段としては、冷感剤の配合が挙げられる。 On the other hand, as a means for imparting a feeling of preventing bad breath to the oral composition, a cooling sensation agent may be added.
 例えば、特許文献1には、N-(4-シアノメチルフェニル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドと、ポリアクリル酸ナトリウム及び/又はアルギン酸ナトリウムとを含む歯磨剤組成物は、持続的かつ高い口腔内清浄感及び良好な使用感を提供できることが記載されている。特許文献2には、キレート剤及びN-(4-シアノメチルフェニル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミドを含む歯磨剤組成物が、高い口腔内清掃実感と共に優れた口臭予防実感を与えることが記載されている。特許文献3には、ポリリン酸化化合物とメントール等の冷感剤を含む口腔ケア組成物は、白化及び染み予防効果を有することが記載されている。 For example, in Patent Document 1, a dentin composition containing N- (4-cyanomethylphenyl) -2-isopropyl-5-methylcyclohexanecarboxamide and sodium polyacrylate and / or sodium alginate is described as persistent. It is described that it can provide a high oral cleanliness and a good feeling of use. According to Patent Document 2, a dentifrice composition containing a chelating agent and N- (4-cyanomethylphenyl) -2-isopropyl-5-methylcyclohexanecarboxamide gives a high oral cleaning sensation and an excellent halitosis prevention sensation. Is described. Patent Document 3 describes that an oral care composition containing a polyphosphorylated compound and a cooling sensation agent such as menthol has a whitening and stain-preventing effect.
国際公開第2018/221620号International Publication No. 2018/221620 国際公開第2018/221617号International Publication No. 2018/221617 特表2009-531425号公報Special Table 2009-531425 Gazette
 しかし、特許文献1~3に記載されている組成物における従来のキレート剤と冷感剤の組み合わせでは、冷感剤による舌への刺激から、歯の汚れがきれいに除去できているにも関わらず「歯の表面のツルツル感」を十分に実感することができない場合がある。特に、口臭予防実感に求められる持続性を向上させるために冷感剤を増量すると、舌の感覚への影響が大きくなり、歯のツルツル感は更に感じにくくなる。 However, in the combination of the conventional chelating agent and the cooling sensation agent in the compositions described in Patent Documents 1 to 3, the stains on the teeth can be cleanly removed from the irritation of the tongue by the cooling sensation agent. It may not be possible to fully realize the "smoothness of the tooth surface". In particular, if the amount of the cooling sensation agent is increased in order to improve the sustainability required for the feeling of prevention of bad breath, the influence on the sensation of the tongue becomes large, and the smooth feeling of the teeth becomes more difficult to feel.
 本発明は、上記従来技術の問題点に鑑み、口腔内の刺激を抑制しつつ、口臭予防実感とツルツル感の両方を発揮し得る口腔用組成物を提供することを目的とする。 In view of the above-mentioned problems of the prior art, an object of the present invention is to provide an oral composition capable of exhibiting both a feeling of preventing bad breath and a feeling of slipperiness while suppressing irritation in the oral cavity.
 すなわち、本発明は、以下の〔1〕~〔11〕を提供する。
〔1〕(A)キレート剤と、
 (B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドと
を含有する口腔用組成物。
〔2〕(A)成分が、縮合リン酸、有機酸、及びそれらの塩、並びにポリアクリル酸塩からなる群より選ばれる1種以上を含む〔1〕に記載の口腔用組成物。
〔3〕(A)成分が、以下の少なくともいずれか1つを含む、〔1〕に記載の口腔用組成物:
 ピロリン酸、ポリリン酸、ヘキサメタリン酸及びそれらの塩からなる群より選ばれる1種以上である縮合リン酸及びその塩;
 リンゴ酸、酒石酸、クエン酸、コハク酸、乳酸、フィチン酸、及びそれらの塩からなる群より選ばれる1種以上である有機酸及びその塩;及び、
 ポリアクリル酸ナトリウムであるポリアクリル酸塩。
〔4〕(A)成分の含有量が0.1~3質量%である〔1〕~〔3〕のいずれか1項に記載の口腔用組成物。
〔5〕(B)成分の含有量が0.00001~0.1質量%である〔1〕~〔4〕のいずれか1項に記載の口腔用組成物。
〔6〕(C)研磨剤をさらに含有する、〔1〕~〔5〕のいずれか1項に記載の口腔用組成物。
〔7〕(C)成分の含有量が2~30質量%である〔6〕に記載の口腔用組成物。
〔8〕(C)成分が、無水ケイ酸及び酸化アルミニウムからなる群より選ばれる1種以上である、〔6〕又は〔7〕に記載の口腔用組成物。
〔9〕(D)炭素原子数6~12のラクトンをさらに含有する、〔1〕~〔8〕のいずれか1項に記載の口腔用組成物。
〔10〕(D)成分の含有量が、0.000001~0.2質量%である、〔9〕に記載の口腔用組成物。
〔11〕歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤である〔1〕~〔10〕のいずれか1項に記載の口腔用組成物。
That is, the present invention provides the following [1] to [11].
[1] (A) Chelating agent and
(B) An oral composition containing N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
[2] The oral composition according to [1], wherein the component (A) contains at least one selected from the group consisting of condensed phosphoric acid, organic acids, salts thereof, and polyacrylic acid salts.
[3] The oral composition according to [1], wherein the component (A) contains at least one of the following:
Condensed phosphoric acid and its salt, which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid and salts thereof;
One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof; and salts thereof;
Polyacrylic acid salt which is sodium polyacrylate.
[4] The oral composition according to any one of [1] to [3], wherein the content of the component (A) is 0.1 to 3% by mass.
[5] The oral composition according to any one of [1] to [4], wherein the content of the component (B) is 0.00001 to 0.1% by mass.
[6] The oral composition according to any one of [1] to [5], further containing (C) an abrasive.
[7] The oral composition according to [6], wherein the content of the component (C) is 2 to 30% by mass.
[8] The oral composition according to [6] or [7], wherein the component (C) is at least one selected from the group consisting of silicic anhydride and aluminum oxide.
[9] The oral composition according to any one of [1] to [8], further containing (D) a lactone having 6 to 12 carbon atoms.
[10] The oral composition according to [9], wherein the content of the component (D) is 0.000001 to 0.2% by mass.
[11] The oral composition according to any one of [1] to [10], which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
 本発明によれば、口腔内の刺激を抑制しつつ、口臭予防実感とツルツル感の両方を発揮し得る口腔用組成物が提供される。 According to the present invention, there is provided an oral composition capable of exhibiting both a feeling of preventing bad breath and a feeling of smoothness while suppressing irritation in the oral cavity.
 以下、本発明について詳細に説明する。
 本発明の口腔用組成物は、下記(A)及び(B)成分を含有し、好ましくは(C)成分を更に含有する。
Hereinafter, the present invention will be described in detail.
The oral composition of the present invention contains the following components (A) and (B), and preferably further contains the component (C).
[(A)成分]
 (A)成分は、キレート剤である。(A)成分を含有することにより、化学的作用によりステインが除去され、歯の表面が滑らかとなり、ツルツルさせることができる。キレート剤としては、例えば、縮合リン酸及びその塩、有機酸及びその塩、並びにポリアクリル酸塩が挙げられる。すなわち、(A)成分は、縮合リン酸、有機酸、及びそれらの塩、並びにポリアクリル酸塩からなる群より選ばれる1種以上を含むことが好ましい。
[(A) component]
The component (A) is a chelating agent. By containing the component (A), stains are removed by chemical action, and the tooth surface becomes smooth and smooth. Examples of the chelating agent include condensed phosphoric acid and its salt, organic acid and its salt, and polyacrylic acid salt. That is, the component (A) preferably contains one or more selected from the group consisting of condensed phosphoric acid, organic acids, salts thereof, and polyacrylic acid salts.
 縮合リン酸及びその塩としては、例えば、ピロリン酸、トリポリリン酸、テトラポリリン酸、より高重合度のポリリン酸等の直鎖状のポリリン酸及びそれらの塩;トリメタリン酸、テトラメタリン酸、ヘキサメタリン酸等の環状のポリリン酸及びそれらの塩が挙げられる。塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩が挙げられる。縮合リン酸及びその塩としては、ピロリン酸塩、ポリリン酸塩、ヘキサメタリン酸塩が好ましく、ピロリン酸ナトリウム、ポリリン酸ナトリウム、ヘキサメタリン酸ナトリウムがより好ましい。 Condensed phosphoric acid and salts thereof include linear polyphosphoric acids such as pyrophosphoric acid, tripolyphosphoric acid, tetrapolyphosphoric acid, and polyphosphoric acid having a higher degree of polymerization and salts thereof; trimetaphosphate, tetramethaphosphate, hexametaphosphate. Such as cyclic polyphosphoric acid and salts thereof. Examples of the salt include alkali metal salts such as sodium salt and potassium salt. As the condensed phosphoric acid and a salt thereof, pyrophosphate, polyphosphate and hexametaphosphate are preferable, and sodium pyrophosphate, sodium polyphosphate and sodium hexametaphosphate are more preferable.
 有機酸及びその塩としては、例えば、シュウ酸、マロン酸、マレイン酸、フマル酸、乳酸、リンゴ酸、酒石酸、クエン酸、ピルビン酸、オキサロ酢酸、アスパラギン酸、コハク酸、グルクロン酸、アジピン酸、フィチン酸、フタル酸、酢酸、及びそれらの塩(例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩)が挙げられる。中でもリンゴ酸、酒石酸、クエン酸、コハク酸、乳酸、及びフィチン酸、及びそれらの塩が好ましく、リンゴ酸、フィチン酸又はそれらの塩がより好ましい。
 ポリアクリル酸塩としては、直鎖型のポリアクリル酸塩を使用することができ、重量平均分子量(Mw)が1,000以上20,000以下であるポリアクリル酸塩を使用することが好ましい。ここで、重量平均分子量は、下記の条件により、ゲル浸透クロマトグラフ/多角度レーザー光散乱検出器(GPC-MALLS)を用いて測定することができる。
移動相:0.3M NaClO
NaN水溶液カラム:TSKgelα-M 2本
プレカラム:TSK guardcolumn α
標準物質:ポリエチレングリコール
Examples of the organic acid and its salt include oxalic acid, malonic acid, maleic acid, fumaric acid, lactic acid, malic acid, tartrate acid, citric acid, pyruvate acid, oxaloacetic acid, aspartic acid, succinic acid, glucuronic acid, adipic acid, and the like. Examples thereof include phytic acid, phthalic acid, acetic acid, and salts thereof (for example, alkali metal salts such as sodium salt and potassium salt). Among them, malic acid, tartaric acid, citric acid, succinic acid, lactic acid, and phytic acid, and salts thereof are preferable, and malic acid, phytic acid, or salts thereof are more preferable.
As the polyacrylic acid salt, a linear polyacrylic acid salt can be used, and it is preferable to use a polyacrylic acid salt having a weight average molecular weight (Mw) of 1,000 or more and 20,000 or less. Here, the weight average molecular weight can be measured using a gel permeation chromatograph / multi-angle laser light scattering detector (GPC-MALLS) under the following conditions.
Mobile phase: 0.3M NaClO 4
NaN 3 aqueous solution column: TSKgelα-M 2 pre-columns: TSK guardgroup α
Standard substance: Polyethylene glycol
 ポリアクリル酸塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩が挙げられる。ポリアクリル酸塩は、ポリアクリル酸ナトリウムであることが好ましい。
 (A)成分は、1種でも2種以上の組み合わせでもよい。
 (A)成分は、以下の少なくともいずれか1つを含むことが好ましい:
 ピロリン酸、ポリリン酸、ヘキサメタリン酸、及びそれらの塩からなる群より選ばれる1種以上である縮合リン酸及びその塩;
 リンゴ酸、酒石酸、クエン酸、コハク酸、乳酸、フィチン酸、及びそれらの塩からなる群より選ばれる1種以上である有機酸及びその塩;及び、
 ポリアクリル酸ナトリウムであるポリアクリル酸塩。
Examples of the polyacrylic acid salt include alkali metal salts such as sodium salt and potassium salt. The polyacrylic acid salt is preferably sodium polyacrylate.
The component (A) may be one kind or a combination of two or more kinds.
The component (A) preferably contains at least one of the following:
Condensed phosphoric acid and its salt, which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid, and salts thereof;
One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof; and salts thereof;
Polyacrylic acid salt which is sodium polyacrylate.
 (A)成分の含有量は、口腔用組成物全体(100質量%)に対し、通常、0.05質量%以上、好ましくは0.1質量%以上である。これにより、より良好なステイン除去効果を得ることができる。上限は、通常、3.5質量%以下、好ましくは、3質量%以下、より好ましくは、2.5質量%以下である。これにより、口腔への過剰な刺激による使用感の低下を抑制できる。従って、(A)成分の含有量は、通常、0.05~3.5質量%、好ましくは、0.1~3質量%、より好ましくは0.1~2.5質量%である。 The content of the component (A) is usually 0.05% by mass or more, preferably 0.1% by mass or more, based on the entire oral composition (100% by mass). Thereby, a better stain removing effect can be obtained. The upper limit is usually 3.5% by mass or less, preferably 3% by mass or less, and more preferably 2.5% by mass or less. As a result, it is possible to suppress a decrease in usability due to excessive stimulation to the oral cavity. Therefore, the content of the component (A) is usually 0.05 to 3.5% by mass, preferably 0.1 to 3% by mass, and more preferably 0.1 to 2.5% by mass.
[(B)成分]
 (B)成分は、N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドである。(B)成分を含有することにより、口臭予防実感効果とその持続性が発揮できる。(B)成分は、舌刺激が生じにくいため、ツルツル感を損なわずに上記効果を得ることができる。
[(B) component]
The component (B) is N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide. By containing the component (B), the effect of preventing bad breath and its sustainability can be exhibited. Since the component (B) is less likely to cause tongue irritation, the above effect can be obtained without impairing the smooth feeling.
 (B)成分の含有量は、口腔用組成物全体(100質量%)に対し、通常、0.000005質量%以上、好ましくは0.00001質量%以上、より好ましくは、0.00005質量%以上である。これにより、良好な口臭予防実感を得ることができる。上限は、通常、0.5質量%以下、好ましくは、0.1質量%以下、より好ましくは、0.005質量%以下である。これにより、刺激が強くなり過ぎてツルツル感も低下することを抑制できる。従って、(A)成分の含有量は、通常、0.000005~0.5質量%、好ましくは、0.00001~0.1質量%、より好ましくは、0.00005~0.005質量%である。 The content of the component (B) is usually 0.000005% by mass or more, preferably 0.00001% by mass or more, more preferably 0.00005% by mass or more, based on the entire oral composition (100% by mass). Is. As a result, a good feeling of prevention of bad breath can be obtained. The upper limit is usually 0.5% by mass or less, preferably 0.1% by mass or less, and more preferably 0.005% by mass or less. As a result, it is possible to prevent the stimulus from becoming too strong and the slippery feeling from being lowered. Therefore, the content of the component (A) is usually 0.000005 to 0.5% by mass, preferably 0.00001 to 0.1% by mass, and more preferably 0.00005 to 0.005% by mass. be.
[(C)成分]
 (C)成分は、研磨剤である。(C)成分を含有することにより、物理的作用によるステイン除去効果を得ることができる。
 研磨剤としては、無機研磨剤及び有機研磨剤のいずれでもよい。研磨剤の好ましいRDA値(Radioactive Dentine Abrasion Values)に特に制限はない。RDA値は、通常50以上、特に50~200であることが好ましい。無機研磨剤としては、例えば、無水ケイ酸、結晶性シリカ、非晶性シリカ、シリカゲル、アルミノシリケート、ジルコノシリケート、ゼオライト、沈降性シリカ、チタン結合性シリカ等のシリカ系研磨剤;リン酸水素カルシウム無水和物、リン酸水素カルシウム2水和物、第1リン酸カルシウム、第3リン酸カルシウム、ピロリン酸カルシウム、不溶性メタリン酸カルシウム、第3リン酸カルシウム、第4リン酸カルシウム、第8リン酸カルシウム等のリン酸カルシウム;炭酸カルシウム(軽質、重質)、水酸化カルシウム、硫酸カルシウム等のカルシウム塩;炭酸水素ナトリウム;水酸化アルミニウム、酸化アルミニウム、アルミナ等のアルミニウム系研磨剤;炭酸マグネシウム、第3リン酸マグネシウムのマグネシウム塩;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト類;ベントナイト;二酸化チタンが挙げられる。有機研磨剤としては、例えば、合成樹脂系研磨剤、ポリメチルメタアクリレートが挙げられる。中でも、無機研磨剤が好ましく、シリカ系研磨剤及びアルミニウム系研磨剤がより好ましく、無水ケイ酸及び酸化アルミニウムからなる群より選ばれる1種以上がより好ましい。
[(C) component]
The component (C) is an abrasive. By containing the component (C), a stain removing effect due to a physical action can be obtained.
The abrasive may be either an inorganic abrasive or an organic abrasive. The preferred RDA value (Radioactive Dentin Abrasion Values) of the abrasive is not particularly limited. The RDA value is usually 50 or more, particularly preferably 50 to 200. Examples of the inorganic polishing agent include silica-based polishing agents such as anhydrous silicic acid, crystalline silica, amorphous silica, silica gel, aluminosilicate, zirconosilicate, zeolite, precipitated silica, and titanium-binding silica; hydrogen phosphate. Calcium Anhydrous, Calcium Hydrogen Phosphate Dihydrate, 1st Calcium Phosphate, 3rd Calcium Phosphate, Calcium Pyrophosphate, Insoluble Calcium Metaphosphate, 3rd Calcium Phosphate, 4th Calcium Phosphate, 8th Calcium Phosphate and other Calcium Phosphate; Calcium Carbonate (Light, Heavy) Quality), calcium salts such as calcium hydroxide and calcium sulfate; sodium hydrogen carbonate; aluminum-based abrasives such as aluminum hydroxide, aluminum oxide and alumina; magnesium salts of magnesium carbonate and tertiary magnesium phosphate; hydroxyapatite and fluoroapatite , Apatites such as calcium-deficient apatite; bentonite; titanium dioxide. Examples of the organic abrasive include synthetic resin-based abrasives and polymethylmethacrylate. Among them, an inorganic abrasive is preferable, a silica-based abrasive and an aluminum-based abrasive are more preferable, and one or more selected from the group consisting of silicic acid anhydride and aluminum oxide is more preferable.
 研磨性シリカは、平均粒径が1~40μmである研磨粒子であることが好ましく、また、研磨性シリカのBET比表面積は、1gあたり80~250平方メートルであることが好ましい。ここで、研磨性シリカの平均粒径はレーザー回折・散乱法で測定される、体積基準のメジアン径(D50)である。シリカ系研磨剤としては、市販品を使用でき、例えば、Evonic社製のZEODENT(登録商標)124、ZEODENT(登録商標)113、Solvay社製のTixosil(登録商標) 73、Tixosil(登録商標) 63、多木化学(株)製の研磨性シリカ、ジルコノシリケート、アルミノシリケート等が挙げられる。 The abrasive silica is preferably abrasive particles having an average particle size of 1 to 40 μm, and the BET specific surface area of the abrasive silica is preferably 80 to 250 square meters per gram. Here, the average particle size of the abrasive silica is a volume-based median diameter (D50) measured by a laser diffraction / scattering method. Commercially available products can be used as the silica-based polishing agent, for example, ZEODENT (registered trademark) 124, ZEODENT (registered trademark) 113 manufactured by Evonic, Tixosil (registered trademark) 73, Tixosil (registered trademark) 63 manufactured by Solvay. , Polishable silica, zirconosilicate, aluminosilicate, etc. manufactured by Taki Chemical Co., Ltd. can be mentioned.
 研磨剤は、造粒物でもよい。斯かる造粒物としては、例えば、水不溶性粉体(例えば、シリカゲル)を顆粒状に造粒してなる粒子が挙げられる。顆粒状に造粒する際、従来公知の任意好適な結合剤を用いてもよい。
 (C)成分は、1種単独でも、2種以上の組み合わせでもよい。2種以上の組み合わせの場合、上記研磨粒子と造粒物の組み合わせを含んでもよい。
The abrasive may be a granulated product. Examples of such granulated products include particles obtained by granulating water-insoluble powder (for example, silica gel) into granules. When granulating into granules, a conventionally known arbitrary suitable binder may be used.
The component (C) may be used alone or in combination of two or more. In the case of a combination of two or more kinds, the combination of the above-mentioned abrasive particles and the granulated product may be included.
 口腔用組成物が(C)成分を含む場合、その含有量は、口腔用組成物全体(100質量%)に対し、通常、1質量%以上、好ましくは2質量%以上である。これにより、ステイン等の汚れに対する清掃力を高めることができる。上限は、通常、35質量%以下、好ましくは、30質量%以下、より好ましくは、20質量%以下である。これにより、口腔粘膜刺激性の発生を抑制できる。従って、(C)成分の含有量は、通常、1~35質量%、好ましくは、2~30質量%、より好ましくは、2~20質量%である。 When the oral composition contains the component (C), the content thereof is usually 1% by mass or more, preferably 2% by mass or more, based on the entire oral composition (100% by mass). This makes it possible to enhance the cleaning power against stains such as stains. The upper limit is usually 35% by mass or less, preferably 30% by mass or less, and more preferably 20% by mass or less. Thereby, the occurrence of oral mucosal irritation can be suppressed. Therefore, the content of the component (C) is usually 1 to 35% by mass, preferably 2 to 30% by mass, and more preferably 2 to 20% by mass.
[(D)成分]
 (D)成分は、炭素原子数6~12のラクトンである(以下、炭素原子数を、炭素原子を表す「C」に付した数字として示す。)。すなわち、口腔用組成物は、(D)成分であるラクトンをさらに含有することが好ましい。(D)成分である炭素原子数6~12のラクトンにおいて、環構造を構成する炭素原子数は特に限定されない。
[(D) component]
The component (D) is a lactone having 6 to 12 carbon atoms (hereinafter, the number of carbon atoms is shown as a number attached to "C" representing a carbon atom). That is, it is preferable that the oral composition further contains the lactone which is the component (D). In the lactone having 6 to 12 carbon atoms as the component (D), the number of carbon atoms constituting the ring structure is not particularly limited.
 (D)成分を含有することにより、口腔用組成物の使用中及び使用後における甘味感を付与し(A)成分由来の苦みを抑制することで、使用感を向上させることができる。 By containing the component (D), the oral composition can be given a sweetness during and after use, and the bitterness derived from the component (A) can be suppressed, thereby improving the feeling of use.
 (D)成分としては、具体的には、例えば、C6:γ-ヘキサラクトン、C7:γ-ヘプタラクトン、C8:γ-オクタラクトン、C9:γ-ノナラクトン、C10:γ-デカラクトン、C11:γ-ウンデカラクトン、C12:γ-ドデカラクトン、C6:δ-ヘキサラクトン、C7:δ-ヘプタラクトン、C8:δ-オクタラクトン、C9:δ-ノナラクトン、C10:δ-デカラクトン、C11:δ-ウンデカラクトン、C12:δ―ドデカラクトンが挙げられる。(D)成分としては、炭素原子数6~11のラクトンを用いることが好ましく、具体的には5員環を含むラクトン(γ-ラクトン)、6員環を含むラクトン(δ-ラクトン)を用いることが好ましく、5員環を含むラクトン(γ-ラクトン)を用いることがより好ましい。(D)成分としては、これらの1種又は2種以上を使用することができる。すなわち、口腔用組成物は、(D)成分として、炭素原子数6~12のラクトンからなる群より選ばれる1種以上をさらに含有することが好ましい。 Specific examples of the component (D) include C6: γ-hexalactone, C7: γ-heptalactone, C8: γ-octalactone, C9: γ-nonalactone, C10: γ-decalactone, and C11: γ. -Undecalactone, C12: γ-dodecalactone, C6: δ-hexalactone, C7: δ-heptalactone, C8: δ-octalactone, C9: δ-nonalactone, C10: δ-decalactone, C11: δ-un Decalactone, C12: δ-dodecalactone. As the component (D), it is preferable to use a lactone having 6 to 11 carbon atoms, and specifically, a lactone containing a 5-membered ring (γ-lactone) and a lactone containing a 6-membered ring (δ-lactone) are used. It is preferable to use a lactone containing a 5-membered ring (γ-lactone). As the component (D), one or more of these can be used. That is, it is preferable that the oral composition further contains at least one selected from the group consisting of lactones having 6 to 12 carbon atoms as the component (D).
 口腔用組成物が(D)成分を含む場合、その含有量は、口腔用組成物全体(100質量%)に対し、通常、0.000001質量%以上、好ましくは0.000005質量%以上、より好ましくは、0.00001質量%以上である。これにより、良好な甘さを付与し苦みを抑制することができる。上限は、通常、0.2質量%以下、好ましくは、0.1質量%以下、より好ましくは、0.05質量%以下である。これにより、甘味感が強くなり過ぎて口腔用組成物の使用感が低下することを抑制できる。従って、(D)成分の含有量は、通常、0.000001~0.2質量%、好ましくは、0.000005~0.1質量%、より好ましくは、0.00001~0.05質量%である。 When the oral composition contains the component (D), the content thereof is usually 0.0000001% by mass or more, preferably 0.000005% by mass or more, based on the total amount of the oral composition (100% by mass). It is preferably 0.00001% by mass or more. As a result, good sweetness can be imparted and bitterness can be suppressed. The upper limit is usually 0.2% by mass or less, preferably 0.1% by mass or less, and more preferably 0.05% by mass or less. As a result, it is possible to prevent the sweetness from becoming too strong and the oral composition from being used poorly. Therefore, the content of the component (D) is usually 0.000001 to 0.2% by mass, preferably 0.000005 to 0.1% by mass, and more preferably 0.00001 to 0.05% by mass. be.
[任意成分]
 口腔用組成物は、本発明の効果を損なわない範囲で、既に説明した(A)~(D)成分以外の任意成分を含有していてもよい。
[Arbitrary ingredient]
The oral composition may contain any component other than the components (A) to (D) already described, as long as the effect of the present invention is not impaired.
 任意成分としては、例えば、界面活性剤、甘味剤、香料、薬用成分、油性成分、防腐剤、湿潤剤、粘結剤、pH調整剤、着色剤(色素)、溶媒が挙げられる。以下、具体的に説明する。 Examples of the optional component include a surfactant, a sweetener, a fragrance, a medicinal component, an oily component, a preservative, a wetting agent, a binder, a pH adjuster, a colorant (dye), and a solvent. Hereinafter, a specific description will be given.
-界面活性剤-
 (C)成分以外の界面活性剤としては、例えば、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤が挙げられる。
-Surfactant-
Examples of the surfactant other than the component (C) include an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant.
 アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20であり、好ましくは12~18であり、より好ましくは12~14である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩がさらに好ましい。 Examples of the anionic surfactant include alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates. The alkyl group and the acyl group may be either a straight chain or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14. The salt can be selected from pharmacologically acceptable salts. Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt; organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt; arginine salt and the like. Basic amino acid salts of. Of these, inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
 アルキル硫酸塩としては、例えば、ラウリル硫酸塩(ラウリル硫酸ナトリウム)、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルサルコシン塩、ミリストイルサルコシン塩等のアシルサルコシン塩;ラウロイルグルタミン酸塩、ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、テトラデセンスルホン酸塩等の炭素原子数12~18のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。 Examples of the alkyl sulfate include lauryl sulfate (sodium lauryl sulfate) and myristyl sulfate. Examples of the acyl amino acid salt include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine. Acylglycine salts such as salts; N-lauroyl-β-alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl Acylalanine salts such as -N-methyl-β-alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned. Examples of the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt. Examples of the α-olefin sulfonate include α-olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate. Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
 アニオン界面活性剤は、泡立ち、泡質の良さの点で、スルホン酸基を含有することが好ましく、アルキル硫酸塩、α-オレフィンスルホン酸塩がより好ましい。 The anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an α-olefin sulfonate.
 ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル鎖の炭素原子数は、通常、14~18であり、エチレンオキサイド平均付加モル数は、通常、5~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常20~100モル、好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ノニオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテルが好ましい。 Examples of the nonionic surfactant include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkyrrole amide, and polyoxy. Ethylene fatty acid esters, polyoxyethylene alkenyl ethers, glycerin fatty acid esters, sucrose fatty acid esters (eg, Martose fatty acid esters), sugar alcohol fatty acid esters (eg, multitoll fatty acid esters, lactitol fatty acid esters), fatty acid diethanolamides (eg, lauryl). Acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like. The number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 5 to 30 mol. The average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol. The number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18. The number of carbon atoms of the fatty acid of the polyoxyethylene sorbitan fatty acid ester is usually 16 to 18, and the average number of moles of ethylene oxide added is usually 10 to 40 mol. The number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14. As the nonionic surfactant, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether are preferable.
 両性界面活性剤としては、例えば、アルキルジメチルアミノ酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン)、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(例えば、コカミドプロピルベタイン)等のベタイン型両性界面活性剤;N-脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミン塩(例えば、N-ヤシ油脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン)、ヤシ油脂肪酸イミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン等のイミダゾリン型両性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン等のアルキルベタインが挙げられる。カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。 Examples of the amphoteric surfactant include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-. Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt (eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl Examples include imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine; alkyl betaines such as lauryldimethylaminoacetic acid betaine. Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
 界面活性剤の含有量は、口腔用組成物全体(100質量%)に対し、好ましくは5質量%以下であり、好ましくは0.1~5質量%、より好ましくは0.5~3質量%、さらに好ましくは1~3質量%である。 The content of the surfactant is preferably 5% by mass or less, preferably 0.1 to 5% by mass, and more preferably 0.5 to 3% by mass with respect to the entire oral composition (100% by mass). , More preferably 1 to 3% by mass.
-湿潤剤-
 口腔用組成物が湿潤剤を含むことにより、使用感をより向上させることができる。
-Wetting agent-
When the oral composition contains a wetting agent, the feeling of use can be further improved.
 湿潤剤としては、糖アルコール、糖アルコール以外の多価アルコールが好ましい。糖アルコールとしては、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール、還元澱粉糖化物等の糖アルコール;グリセリン;エチレングリコール、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコール等の多価アルコールが挙げられる。ポリエチレングリコールとしては、例えば、平均分子量150~6000のポリエチレングリコールが挙げられ、好ましくは、平均分子量190~630のポリエチレングリコールである。具体的には、PEG200、PEG300、PEG400、PEG600が挙げられる。ポリエチレングリコールの平均分子量は、医薬部外品原料規格2006記載の平均分子量である。湿潤剤の含有量は、口腔用組成物全体(100質量%)に対し、通常、40質量%以下であり、好ましくは1~30質量%である。 As the wetting agent, sugar alcohols and polyhydric alcohols other than sugar alcohols are preferable. Examples of the sugar alcohol include sugar alcohols such as sorbitol, erythritol, martitol, lactitol, xylitol, and reduced starch saccharified; glycerin; polyhydric alcohols such as ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol. Can be mentioned. Examples of the polyethylene glycol include polyethylene glycol having an average molecular weight of 150 to 6000, and polyethylene glycol having an average molecular weight of 190 to 630 is preferable. Specific examples thereof include PEG200, PEG300, PEG400 and PEG600. The average molecular weight of polyethylene glycol is the average molecular weight described in the Quasi-drug Raw Material Standard 2006. The content of the wetting agent is usually 40% by mass or less, preferably 1 to 30% by mass, based on the entire oral composition (100% by mass).
-薬用成分-
 薬用成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、グリチルリチン酸塩(例えば、グリチルリチン2カリウム塩)、グリチルレチン酸、グリチルレチン酸誘導体(例えば、グリチルレチン酸ステアリル)、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛塩、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム等の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬用成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬用成分の含有量は、常法に従って有効量を適宜設定できる。
-Medicated ingredients-
Examples of medicinal ingredients include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timol, hinokithiol, and lysoteam chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, glycyrrhizinate (eg, glycyrrhetin dipotassium salt) ), Glycyrrhetinic acid, glycyrrhetinic acid derivative (eg, stearyl glycyrrhetinate), anti-inflammatory agents such as allantinchlorhydroxyaluminum, azulene, dihydrocholesterol; metal salts such as zinc salt, copper salt, tin salt; condensed phosphate, ethane Toothstone preventive agent such as hydroxydiphosphonate; Blood flow promoter such as vitamin E (for example, tocopherol acetate); Sensitivity inhibitor such as potassium nitrate, aluminum lactate, strontium chloride; Coating agent such as hydroxyethylcellulosedimethyldiallylammonium chloride Astringents such as vitamin C (eg, ascorbic acid or a salt thereof), lysoteam chloride; water-soluble copper compounds such as copper chlorophyll and copper gluconate; , Chouji, Hamamelis and other plant extracts; caropeptide, polyvinylpyrrolidone and the like. The medicinal ingredient may be used alone or in combination of two or more. The content of the above medicinal component can be appropriately set as an effective amount according to a conventional method.
-香料-
 口腔用組成物が任意の(D)成分以外の香料を含むことにより、使用感をより向上させることができる。任意のD成分以外の香料としては、例えば、ペパーミント油、スペアミント油、和種ハッカ油、アニス油、カシア油、ユーカリ油、ウィンターグリーン油、マスチック油、ネロリ油(オレンジフラワー油)、レモングラス油、ジャスミン油、ローズ油、イリス油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、バジル油、マジョラム油、レモン油、オレンジ油、ライム油、柚子油、ナツメグ油、ラベンダー油、パラクレス油、バニラ油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、デカナール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、エチレングリコール-l-メンチルカーボネート等の香料成分;及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、本発明の効果を損なわない範囲で、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Fragrance-
When the oral composition contains a fragrance other than the arbitrary component (D), the feeling of use can be further improved. Examples of fragrances other than any D component include peppermint oil, sparemint oil, Japanese peppermint oil, anis oil, cassia oil, eucalyptus oil, winter green oil, mastic oil, neroli oil (orange flower oil), and lemongrass oil. , Jasmine oil, rose oil, iris oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, laurel oil, camomill oil, caraway oil, basil oil, majorum oil, lemon oil, orange oil, lime oil , Yuzu oil, Natsumeg oil, Lavender oil, Paracres oil, Vanilla oil, Katsura skin oil, Pimento oil, Katsura leaf oil, Perilla oil, Winter green oil and other natural essential oils; Cineol, methylsalicylate, eugenol, timol, linalol, limonen, menton, mentylacetate, citral, decanal, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, ethyllinalol, Fragrance components contained in the above natural essential oils such as crocodile; ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenylglycidate, benzaldehyde, vanillin, ethyl vanillin, flaneol, N-ethyl -P-mentan-3-carboxamide, mentyllactate, ethyleneglycol-l-mentylcarbonate and other fragrance ingredients; and various mint-based, fruit-based, herbal-based, etc. blended flavors made by combining several fragrance ingredients and natural essential oils. Can be mentioned. As the fragrance, the above-exemplified fragrance may be used alone or in combination of two or more as long as the effect of the present invention is not impaired.
-甘味剤-
 口腔用組成物が甘味剤を含むことにより、使用感をより向上させることができる。甘味剤としては、例えば、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Sweetener-
When the oral composition contains a sweetening agent, the feeling of use can be further improved. Examples of the sweetener include saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, aspartylphenylalanine methyl ester and the like. As the sweetener, the above-exemplified sweetener may be used alone or in combination of two or more.
-油性成分-
 油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。
-Oil component-
Examples of the oily component include hydrocarbons such as squalane, liquid paraffin, vaseline, and microcrystalin wax; and having 8 carbon atoms such as higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, and isostearyl alcohol). ~ 22 alcohols); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), vegetable oils such as olive oil, castor oil, palm oil; Examples include fatty acid esters.
-防腐剤-
 口腔用組成物が防腐剤を含むことにより、製剤の防腐力を確保できる。防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Preservative-
When the oral composition contains an antiseptic, the antiseptic power of the preparation can be ensured. Examples of the preservative include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like. The preservative may be used alone or in combination of two or more.
-粘結剤-
 口腔用組成物が任意の粘結剤を含むことにより、粘度を最適化でき、保形性、使用感をより向上させることができる。粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール、アルギン酸プロピレングリコール)が挙げられる。さらには増粘性シリカ、ケイ酸アルミニウム等の無機粘結剤も挙げられる。任意の有機粘結剤の含有量は、口腔用組成物全体(100質量%)に対し、0~3質量%であることが好ましく、0.1~2質量%であることがより好ましい。無機粘結剤の含有量は、0~10質量%が好ましく、1~8質量%がより好ましい。
-Blotting agent-
When the oral composition contains an arbitrary binder, the viscosity can be optimized, and the shape retention and usability can be further improved. As the binder, any suitable organic binder conventionally known, for example, a polysaccharide, a cellulosic binder (for example, carboxymethyl cellulose (CMC), hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, cation) Celluloseized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (eg, sodium polyacrylate, etc.) Cardovinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, propylene glycol alginate) can be mentioned. Further, inorganic binders such as thickening silica and aluminum silicate can also be mentioned. The content of any organic binder is preferably 0 to 3% by mass, more preferably 0.1 to 2% by mass, based on the entire oral composition (100% by mass). The content of the inorganic binder is preferably 0 to 10% by mass, more preferably 1 to 8% by mass.
-pH調整剤-
 口腔用組成物がpH調整剤を含むことにより、製剤のpH安定性を確保できる。任意のpH調整剤としては、例えば、水酸化ナトリウム、水酸化カリウム等の水酸化物、リン酸又はその塩、リン酸水素ナトリウム、リン酸二水素ナトリウム等が挙げられる。
-PH regulator-
When the oral composition contains a pH adjuster, the pH stability of the pharmaceutical product can be ensured. Examples of the optional pH adjuster include hydroxides such as sodium hydroxide and potassium hydroxide, phosphoric acid or a salt thereof, sodium hydrogen phosphate, sodium dihydrogen phosphate and the like.
 pH調整剤の含有量は、通常、添加後の口腔用組成物のpHが5~9、好ましくは6~8.5となる量とすることができる。 The content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
 本明細書において、pH値は、通常、測定開始から25℃、3分後の値をいう。pH値は、例えば、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定することができる。 In the present specification, the pH value usually means a value at 25 ° C. and 3 minutes after the start of measurement. The pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-着色剤-
 着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素や、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、銅クロロフィンナトリウム、二酸化チタン等が挙げられる。口腔用組成物が着色剤を含む場合、その含有量は、口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。
-Colorant-
Examples of the colorant include natural pigments such as Benibana red pigment, Kuchinashi yellow element, Kuchinashi blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and tamarind pigment. Legal dyes such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Riboflavin, Copper Chlorophine Sodium , Titanium dioxide and the like. When the oral composition contains a colorant, the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
-溶媒-
 溶媒としては、例えば、水(精製水)、エタノールが挙げられる。溶媒は1種を単独で用いても2種以上を組み合わせて用いてもよい。
-solvent-
Examples of the solvent include water (purified water) and ethanol. As the solvent, one type may be used alone or two or more types may be used in combination.
-他の任意成分-
 上記以外の任意成分の例としては、ポリイソブチレン、ポリブタジエン、ウレタン、シリコン、天然ゴムが挙げられる。これら他の任意成分の含有量は、本発明の効果を妨げない範囲で適宜設定できる。
-Other optional ingredients-
Examples of optional components other than the above include polyisobutylene, polybutadiene, urethane, silicon, and natural rubber. The content of these other optional components can be appropriately set as long as the effect of the present invention is not impaired.
[口腔用組成物の剤形及び用途]
 本発明の口腔用組成物は、歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤等の口腔用製剤とすることができる。
 口腔用組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ペースト状、液状等の形態で、歯磨剤であれば練歯磨、液体歯磨、液状歯磨、潤製歯磨として調製できる。
[Dosage form and use of oral composition]
The oral composition of the present invention can be an oral preparation such as a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
The dosage form of the oral composition can be appropriately selected depending on the usage form, and is not particularly limited. The dosage form is, for example, in the form of a paste or liquid, and if it is a dentifrice, it can be prepared as a dentifrice, a liquid dentifrice, a liquid dentifrice, or a dentifrice.
〔口腔用組成物の製造方法〕
 口腔用組成物の製造方法は特に限定されない。口腔用組成物は、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧等)を行う方法が挙げられる。このような方法により得られた練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の歯磨剤組成物に使用される容器を使用することができる。容器としては、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック製のラミネートチューブ等の容器等が挙げられる。
[Manufacturing method of oral composition]
The method for producing the oral composition is not particularly limited. Oral compositions can be prepared by their respective conventional methods, depending on the dosage form. For example, when it is used as a dentifrice, a method of preparing a component that dissolves in a solvent, mixing other insoluble components, and defoaming (for example, reducing the pressure) as necessary can be mentioned. The toothpaste obtained by such a method can be contained in a container and made into a product. The shape and material of the container are not particularly limited, and a container used for a normal dentifrice composition can be used. Examples of the container include a container such as a laminated tube made of plastic such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
 以下、実施例及び比較例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、各例中の%はいずれも質量百分率である。 Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples. In addition,% in each example is a mass percentage.
実施例1~21、比較例1~12
 表1~5に示す組成の口腔用組成物(練歯磨剤)を常法によって調製し、通常の口腔用製剤容器(練歯磨:ラミネートチューブ)に収容した。これらをサンプルとして用い、下記に示す方法で評価した。結果を表1~5に併記した。
Examples 1 to 21, Comparative Examples 1 to 12
Oral compositions (dentifrices) having the compositions shown in Tables 1 to 5 were prepared by a conventional method and placed in a normal oral preparation container (dentifrice: laminated tube). These were used as samples and evaluated by the method shown below. The results are also shown in Tables 1-5.
<使用した原料>
-(A)成分-
 A1:ピロリン酸ナトリウム(商品名:ピロリン酸ナトリウム、メーカー:太平化学産業株式会社)
 A2:ポリリン酸ナトリウム(商品名:ポリリン酸ナトリウム、メーカー:太平化学産業株式会社)
 A3:ヘキサメタリン酸ナトリウム(商品名:ヘキサメタリン酸ナトリウム、メーカー:太平化学産業株式会社)
 A4:リンゴ酸(商品名:リンゴ酸、メーカー:扶桑化学工業株式会社)
 A5:フィチン酸(商品名:フィチン酸、メーカー:扶桑化学工業株式会社)
 A6:ポリアクリル酸ナトリウム(商品名:AC-10NPD、メーカー:東亞合成株式会社)
<Ingredients used>
-(A) component-
A1: Sodium pyrophosphate (trade name: sodium pyrophosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
A2: Sodium polyphosphate (trade name: sodium polyphosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
A3: Sodium hexametaphosphate (trade name: sodium hexametaphosphate, manufacturer: Taihei Kagaku Sangyo Co., Ltd.)
A4: Malic acid (trade name: malic acid, manufacturer: Fuso Chemical Industry Co., Ltd.)
A5: Phytic acid (trade name: phytic acid, manufacturer: Fuso Chemical Industry Co., Ltd.)
A6: Sodium polyacrylate (trade name: AC-10NPD, manufacturer: Toagosei Co., Ltd.)
-(B)成分及びその代替成分-
 N-(2‐ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5、5-ジメチルシクロヘキサン-1-カルボキサミド(商品名:Coolact(登録商標)370、メーカー:高砂香料工業株式会社)
 N-エチル-p-メンタン-3-カルボキサミド(商品名:WS-3、シムライズジャパン社製)
 N-(2-(2-ピリジニル)エチル)-2-イソプロピル-5-メチルシクロヘキサンカルボキサミド:(Evercool(登録商標)190、ジボダン社製)
-(B) component and its alternative component-
N- (2-Hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide (trade name: Coolact® 370, manufacturer: Takasago International Corporation)
N-Ethyl-p-Menthane-3-carboxamide (trade name: WS-3, manufactured by Simrise Japan)
N- (2- (2-pyridinyl) ethyl) -2-isopropyl-5-methylcyclohexanecarboxamide: (Evercool® 190, manufactured by Givaudan)
-(C)成分-
 C1:研磨性シリカ:(Tixosil(登録商標) 73、Solvay社製)
 C2:酸化アルミニウム(商品名:酸化アルミニウム、メーカー:日本軽金属株式会社)
-(C) component-
C1: Polishable silica: (Tixosil® 73, manufactured by Solvay)
C2: Aluminum oxide (trade name: aluminum oxide, manufacturer: Nippon Light Metal Co., Ltd.)
-(D)成分-
 D1:γ―ヘキサラクトン:(メーカー:井上香料(株))
 D2:γ―ウンデカラクトン:(メーカー:井上香料(株))
-(D) component-
D1: γ-Hexalactone: (Manufacturer: Inoue Fragrance Co., Ltd.)
D2: γ-Undecalactone: (Manufacturer: Inoue Fragrance Co., Ltd.)
-(A)~(D)成分以外の成分-
 フッ化ナトリウム:(ステラケミファ(株)製)
 ラウリル硫酸ナトリウム:(BASF社製)
 ソルビット液(70%):(三菱商事ライフサイエンス(株)製)
 プロピレングリコール:(ADEKA社製)
 増粘性シリカ:カープレックス(登録商標)#67(DSLジャパン(株)製)
 サッカリンナトリウム:(愛三化学工業(株)製)
 上記以外の成分については医薬部外品原料規格2006に適合した原料を用いた。
-Ingredients other than (A) to (D) components-
Sodium fluoride: (manufactured by Stella Chemipha Co., Ltd.)
Sodium lauryl sulfate: (manufactured by BASF)
Sorbitol liquid (70%): (manufactured by Mitsubishi Corporation Life Science Co., Ltd.)
Propylene glycol: (manufactured by ADEKA)
Viscous silica: Carplex (registered trademark) # 67 (manufactured by DSL Japan Co., Ltd.)
Saccharin sodium: (manufactured by Aisan Chemical Industry Co., Ltd.)
For ingredients other than the above, raw materials conforming to the quasi-drug raw material standard 2006 were used.
<評価方法>
 被験者4名によって評価した。
 歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン(株)製)にサンプルの練歯磨剤1gを載せ、3分間歯みがきを行った後、10mLの水で1回、口腔内をすすいだ。使用後の口腔内の刺激、使用後の歯のツルツル感(ツルツルの実感しやすさ)、口臭予防実感、苦みのなさ、使用感の良さを、それぞれ下記の評点基準によって判定し、4名の平均点を求め、下記の評価基準で評価した。なおここで、口臭予防実感とは、使用後60分経過後もすっきり感を感じることを指し、使用感の良さとは、苦みや甘味が強すぎることによる嫌味がないことを指す。
<Evaluation method>
It was evaluated by 4 subjects.
A 1 g of sample dentifrice was placed on a toothbrush (Clinica Advantage toothbrush, 4-row compact, usually manufactured by Lion Corporation), and after brushing the teeth for 3 minutes, the oral cavity was rinsed once with 10 mL of water. The irritation in the oral cavity after use, the smooth feeling of teeth after use (easiness to feel smooth), the feeling of preventing bad breath, the lack of bitterness, and the good feeling of use are judged by the following score criteria, respectively, for 4 people. The average score was calculated and evaluated according to the following evaluation criteria. Here, the actual feeling of preventing bad breath means that a refreshing feeling is felt even after 60 minutes have passed after use, and the good feeling of use means that there is no sarcasm due to bitterness or too strong sweetness.
<口腔内の刺激>
 評点基準
 5:全く感じない
 4:あまり感じない
 3:わずかに感じる
 2:感じる
 1:非常に感じる
 評価基準
 優:4点以上
 良:3点以上4点未満
 不可:3点未満
<Stimulation in the oral cavity>
Score criteria 5: I don't feel at all 4: I don't feel much 3: I feel a little 2: I feel 1: Very feel Evaluation criteria Excellent: 4 points or more Good: 3 points or more and less than 4 points Impossible: Less than 3 points
<歯のツルツル感>
評点基準
 5:非常に感じる
 4:感じる
 3:やや感じる
 2:あまり感じない
 1:全く感じない
 評価基準
 優:4点以上
 良:3点以上4点未満
 不可:3点未満
<Smoothness of teeth>
Score criteria 5: Very feel 4: Feel 3: Slightly feel 2: Not very feel 1: Not feel at all Evaluation criteria Excellent: 4 points or more Good: 3 points or more and less than 4 points Impossible: Less than 3 points
<口臭予防実感>
 評点基準
 5:非常に感じる
 4:感じる
 3:やや感じる
 2:あまり感じない
 1:全く感じない
 評価基準
 優:4点以上
 良:3点以上4点未満
 不可:3点未満
<Halitosis prevention feeling>
Score criteria 5: Very feel 4: Feel 3: Slightly feel 2: Not very feel 1: Not feel at all Evaluation criteria Excellent: 4 points or more Good: 3 points or more and less than 4 points Impossible: Less than 3 points
<苦みのなさ>
 評点基準
 5:苦みを全く感じない
 4:苦みをほとんど感じない
 3:苦みをわずかに感じるが許容範囲である
 2:苦みを感じる
 1:苦みを非常に感じる
 評価基準
 優:4点以上
 良:3点以上4点未満
 不可:3点未満
<No bitterness>
Rating criteria 5: No bitterness at all 4: Almost no bitterness 3: Slight bitterness but acceptable 2: Feeling bitterness 1: Very bitterness Evaluation criteria Excellent: 4 points or higher Good: 3 Points or more and less than 4 points Impossible: Less than 3 points
<使用感の良さ>
 評点基準
 5:非常に感じる
 4:やや感じる
 3:感じる
 2:あまり感じない
 1:全く感じない
 評価基準
 優:4点以上
 良:3点以上4点未満
 不可:3点未満
<Good usability>
Rating criteria 5: Very felt 4: Slightly felt 3: Feeled 2: Not very felt 1: Not felt at all Evaluation criteria Excellent: 4 points or more Good: 3 points or more and less than 4 points Impossible: Less than 3 points
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 香料の組成は以下の通りである。
 ペパーミント油                 50質量%
 ペパーミント精製油(前流部20%カット)     5質量%
 ペパーミント精製油(前流部・後流部15%カット) 5質量%
 スペアミント油                  1質量%
 スペアミント精製油(前流部20%カット)     1質量%
 和種ハッカ油                   1質量%
 和種ハッカ精製油(前流部30%カット)      1質量%
 メントール                   10質量%
 カルボン                     1質量%
 アネトール                    5質量%
 溶剤                         残部
                     合計 100質量%
The composition of the fragrance is as follows.
Peppermint oil 50% by mass
Peppermint refined oil (20% cut in front flow) 5% by mass
Peppermint refined oil (15% cut in front and back flow) 5% by mass
Spearmint oil 1% by mass
Spearmint refined oil (20% cut in front flow) 1% by mass
Japanese mint oil 1% by mass
Japanese mint refined oil (30% cut in front flow) 1% by mass
Menthol 10% by mass
Carvone 1% by mass
Anethole 5% by mass
Solvent balance 100% by mass in total
 (A)成分を含有するが(B)成分を含有しない比較例1~6では、口臭予防実感の評価が低く、(B)成分を含有するが(A)成分を含有しない比較例7では、歯のツルツル感の評価が低かった。また、(B)成分の代わりに他の冷感剤を含有する比較例8及び9では、口臭予防実感及び歯のツルツル感の評価が低かった。これに対し、(A)及び(B)成分を含有する実施例1~13では、口腔内刺激、歯のツルツル感、及び口臭予防実感のいずれの評価もバランスよく良好であった。中でも、(C)成分を更に含む実施例7、8及び13では、歯のツルツル感の評価がより優れていた。これらの結果は、本発明の口腔用組成物が、口腔内の刺激を抑制しつつ、口臭予防実感とツルツル感の両方を発揮し得ることを示している。さらに、(A)成分及び(B)成分を含有するが(D)成分を含有しない比較例10では苦みが強く、(B)成分及び(D)成分を含有するが(A)成分を含有しない比較例11では苦みがない代わりに歯のツルツル感の評価が低く、(A)成分及び(C)成分を含有するが(B)成分を含有しない比較例12では口臭予防実感の評価が低く、苦みも強く評価された。これに対し、(A)成分、(B)成分及び(D)成分を含有する実施例14~21では、(D)成分をさらに含有することで苦みのなさの評価が優れ、使用感の良さの評価も良好であった。 In Comparative Examples 1 to 6 containing the component (A) but not containing the component (B), the evaluation of the halitosis prevention feeling was low, and in Comparative Example 7 containing the component (B) but not containing the component (A), the evaluation was low. The evaluation of the smoothness of the teeth was low. Further, in Comparative Examples 8 and 9 containing another cooling sensation agent instead of the component (B), the evaluation of the bad breath prevention feeling and the smooth feeling of the teeth was low. On the other hand, in Examples 1 to 13 containing the components (A) and (B), all of the evaluations of the oral irritation, the smooth feeling of the teeth, and the actual feeling of preventing bad breath were well-balanced and good. Among them, in Examples 7, 8 and 13 further containing the component (C), the evaluation of the smoothness of the teeth was more excellent. These results indicate that the oral composition of the present invention can exert both a feeling of preventing bad breath and a feeling of slipperiness while suppressing irritation in the oral cavity. Further, in Comparative Example 10 which contains the component (A) and the component (B) but does not contain the component (D), the bitterness is strong, and the component (B) and the component (D) are contained but the component (A) is not contained. In Comparative Example 11, although there is no bitterness, the evaluation of the smoothness of the teeth is low, and in Comparative Example 12, which contains the components (A) and (C) but does not contain the component (B), the evaluation of the actual feeling of preventing bad breath is low. The bitterness was also strongly evaluated. On the other hand, in Examples 14 to 21 containing the component (A), the component (B) and the component (D), the evaluation of no bitterness is excellent by further containing the component (D), and the usability is good. The evaluation was also good.

Claims (11)

  1.  (A)キレート剤と、
     (B)N-(2-ヒドロキシ-2-フェニルエチル)-2-イソプロピル-5,5-ジメチルシクロヘキサン-1-カルボキサミドと
    を含有する口腔用組成物。
    (A) Chelating agent and
    (B) An oral composition containing N- (2-hydroxy-2-phenylethyl) -2-isopropyl-5,5-dimethylcyclohexane-1-carboxamide.
  2.  (A)成分が、縮合リン酸、有機酸、及びそれらの塩、並びにポリアクリル酸塩からなる群より選ばれる1種以上を含む請求項1に記載の口腔用組成物。 The oral composition according to claim 1, wherein the component (A) contains at least one selected from the group consisting of condensed phosphoric acid, organic acids, salts thereof, and polyacrylic acid salts.
  3.  (A)成分が、以下の少なくともいずれか1つを含む、請求項1に記載の口腔用組成物:
     ピロリン酸、ポリリン酸、ヘキサメタリン酸、及びそれらの塩からなる群より選ばれる1種以上である縮合リン酸及びその塩;
     リンゴ酸、酒石酸、クエン酸、コハク酸、乳酸、フィチン酸、及びそれらの塩からなる群より選ばれる1種以上である有機酸及びその塩;及び、
     ポリアクリル酸ナトリウムであるポリアクリル酸塩。
    The oral composition according to claim 1, wherein the component (A) comprises at least one of the following:
    Condensed phosphoric acid and its salt, which is one or more selected from the group consisting of pyrophosphoric acid, polyphosphoric acid, hexametaphosphoric acid, and salts thereof;
    One or more organic acids selected from the group consisting of malic acid, tartaric acid, citric acid, succinic acid, lactic acid, phytic acid, and salts thereof; and salts thereof;
    Polyacrylic acid salt which is sodium polyacrylate.
  4.  (A)成分の含有量が0.1~3質量%である請求項1~3のいずれか1項に記載の口腔用組成物。 (A) The oral composition according to any one of claims 1 to 3, wherein the content of the component is 0.1 to 3% by mass.
  5.  (B)成分の含有量が0.00001~0.1質量%である請求項1~4のいずれか1項に記載の口腔用組成物。 (B) The oral composition according to any one of claims 1 to 4, wherein the content of the component (B) is 0.00001 to 0.1% by mass.
  6.  (C)研磨剤をさらに含有する、請求項1~5のいずれか1項に記載の口腔用組成物。 (C) The oral composition according to any one of claims 1 to 5, further containing an abrasive.
  7.  (C)成分の含有量が2~30質量%である請求項6に記載の口腔用組成物。 The oral composition according to claim 6, wherein the content of the component (C) is 2 to 30% by mass.
  8.  (C)成分が、無水ケイ酸及び酸化アルミニウムからなる群より選ばれる1種以上である、請求項6又は7に記載の口腔用組成物。 The oral composition according to claim 6 or 7, wherein the component (C) is at least one selected from the group consisting of silicic anhydride and aluminum oxide.
  9.  (D)炭素原子数6~12のラクトンをさらに含有する、請求項1~8のいずれか1項に記載の口腔用組成物。 (D) The oral composition according to any one of claims 1 to 8, further containing a lactone having 6 to 12 carbon atoms.
  10.  (D)成分の含有量が、0.000001~0.2質量%である、請求項9に記載の口腔用組成物。 The oral composition according to claim 9, wherein the content of the component (D) is 0.000001 to 0.2% by mass.
  11.  歯磨剤、洗口剤、スプレー剤、塗布剤、貼付剤、又は口腔内溶解剤である請求項1~10のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 10, which is a dentifrice, a mouthwash, a spray, a coating agent, a patch, or an oral dissolving agent.
PCT/JP2021/043963 2020-12-28 2021-11-30 Composition for oral use WO2022145166A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202180087622.0A CN116634986A (en) 2020-12-28 2021-11-30 Oral composition
JP2022572945A JPWO2022145166A1 (en) 2020-12-28 2021-11-30

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020219313 2020-12-28
JP2020-219313 2020-12-28

Publications (1)

Publication Number Publication Date
WO2022145166A1 true WO2022145166A1 (en) 2022-07-07

Family

ID=82260367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/043963 WO2022145166A1 (en) 2020-12-28 2021-11-30 Composition for oral use

Country Status (3)

Country Link
JP (1) JPWO2022145166A1 (en)
CN (1) CN116634986A (en)
WO (1) WO2022145166A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009531414A (en) * 2006-03-29 2009-09-03 ザ プロクター アンド ギャンブル カンパニー Oral care compositions with improved consumer aesthetics and taste
JP2013035792A (en) * 2011-08-09 2013-02-21 Kao Corp Composition for oral cavity
JP2015204849A (en) * 2007-11-29 2015-11-19 インターコンチネンタル グレート ブランズ エルエルシー Multi-region chewing gum with actives
WO2018131575A1 (en) * 2017-01-10 2018-07-19 高砂香料工業株式会社 Methylmenthol derivative and cool-sensation imparter composition containing same
US20190175486A1 (en) * 2017-12-07 2019-06-13 Johnson & Johnson Consumer Inc. Oral Care Compositions
WO2019131061A1 (en) * 2017-12-27 2019-07-04 ライオン株式会社 Dentifrice composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009531414A (en) * 2006-03-29 2009-09-03 ザ プロクター アンド ギャンブル カンパニー Oral care compositions with improved consumer aesthetics and taste
JP2015204849A (en) * 2007-11-29 2015-11-19 インターコンチネンタル グレート ブランズ エルエルシー Multi-region chewing gum with actives
JP2013035792A (en) * 2011-08-09 2013-02-21 Kao Corp Composition for oral cavity
WO2018131575A1 (en) * 2017-01-10 2018-07-19 高砂香料工業株式会社 Methylmenthol derivative and cool-sensation imparter composition containing same
US20190175486A1 (en) * 2017-12-07 2019-06-13 Johnson & Johnson Consumer Inc. Oral Care Compositions
WO2019131061A1 (en) * 2017-12-27 2019-07-04 ライオン株式会社 Dentifrice composition

Also Published As

Publication number Publication date
CN116634986A (en) 2023-08-22
JPWO2022145166A1 (en) 2022-07-07

Similar Documents

Publication Publication Date Title
EP2100590B2 (en) Oral composition containing crystalline cellulose surface-treated with water-soluble substance
JP2012036172A (en) Toothpaste composition
JP2022000420A (en) Oral cavity composition
JP5397204B2 (en) Oral composition
JP2009274967A (en) Composition for oral spray and preparation for oral cavity
JP5420811B2 (en) Oral composition
CN107613948B (en) Oral composition
JP2006347986A (en) Composition for oral cavity
JP2021095380A (en) Dentifrice composition
JP2015117215A (en) Dentifrice composition
WO2022145166A1 (en) Composition for oral use
JP2019112375A (en) Oral composition
JP7347916B2 (en) dentifrice composition
JPWO2019194068A1 (en) Oral composition and bitterness improver for α-olefin sulfonate
WO2022145163A1 (en) Composition for oral cavity
WO2022075422A1 (en) Dentifrice composition
WO2022145161A1 (en) Composition for oral cavity
WO2022102628A1 (en) Composition for oral cavity
CN111031999B (en) Toothpaste composition
JP7042075B2 (en) Oral composition
WO2022145167A1 (en) Oral composition
WO2022145160A1 (en) Composition for oral cavity
JP2022104290A (en) Composition for oral cavity
WO2021235424A1 (en) Composition for oral cavity
JP2024047742A (en) Dentifrice Composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21915027

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022572945

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202180087622.0

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21915027

Country of ref document: EP

Kind code of ref document: A1